v1
Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively.
Identifier:nobleid.org/w1/20260515/C9523DFB
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/C9523DFB)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims